Risk of Dementia after Exposure to Contrast Media: A Nationwide, Population-Based Cohort Study.
Tung-Min YuYa-Wen ChuangShih-Ting HuangJin-An HuangCheng-Hsu ChenMu-Chi ChungChun-Yi WuPi-Yi ChangChih-Cheng HsuMing-Ju WuPublished in: Biomedicines (2022)
Contrast-medium-associated kidney injury is caused by the infusion of contrast media. Small vessel disease is significantly associated with various diseases, including simultaneous conditions of the kidney and brain, which are highly vulnerable to similar vascular damage and microvascular pathologies. Data to investigate the adverse effect of contrast media on the brain remain extremely lacking. In this study, 11,332,616 NHI enrollees were selected and divided into two groups, exposed and not exposed to a contrast medium during the observation period, from which 1,461,684 pairs were selected for analyses through matching in terms of age, sex, comorbidities, and frequency of outpatient visits during the previous year. In total, 1,461,684 patients exposed to a contrast medium and 1,461,684 controls not exposed to one were enrolled. In multivariable Cox proportional hazard models, patients exposed to a contrast medium had an overall 2.09-fold higher risk of dementia. In multivariable-stratified analyses, the risk of Alzheimer's disease was remarkably high in younger patients without any underlying comorbidity. This study is the first to discover that exposure to contrast media is significantly associated with the risk of dementia. A four-fold increased risk of vascular dementia was observed after exposure to a contrast medium. Further studies on the influence of exposure to contrast media on the brain are warranted.
Keyphrases
- magnetic resonance
- end stage renal disease
- contrast enhanced
- mild cognitive impairment
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- magnetic resonance imaging
- low dose
- machine learning
- multiple sclerosis
- oxidative stress
- cognitive decline
- patient reported outcomes
- electronic health record
- brain injury
- artificial intelligence
- adverse drug
- patient reported